首页> 外文期刊>Scientia pharmaceutica >Simultaneous Estimation of Amlodipine Besylate and Indapamide in a Pharmaceutical Formulation by a High Performance Liquid Chromatographic (RP-HPLC) Method
【24h】

Simultaneous Estimation of Amlodipine Besylate and Indapamide in a Pharmaceutical Formulation by a High Performance Liquid Chromatographic (RP-HPLC) Method

机译:高效液相色谱(RP-HPLC)方法同时估算药物制剂中的苯磺酸氨氯地平和吲达帕胺

获取原文
           

摘要

An isocratic reversed-phase liquid chromatograpic assay method was developed for the quantitative determination of amlodipine besylate (AML) and indapamide (IND) in combined dosage form. A Brownlee C-18, 5 μm column with a mobile phase containing 0.02 M potassium dihydrogen phosphate–methanol (30+70, v/v) total pH-adjusted to 3 using o-phosphoric acid was used. The flow rate was 1.0 mL min?1 and effluents were monitored at 242 nm. The retention times of amlodipine besylate and indapamide were 5.9 min and 3.6 min, respectively. The proposed method was validated with respect to linearity, accuracy, precision, and robustness. The method was successfully applied to the estimation of amlodipine besylate and indapamide in combined tablet dosage forms.
机译:建立了等度反相液相色谱测定方法,用于定量测定组合剂型中的苯磺酸氨氯地平(AML)和吲达帕胺(IND)。使用布朗利C-18,5μm色谱柱,其流动相包含0.02 M磷酸二氢钾-甲醇(30 + 70,v / v),总pH使用邻磷酸调节至3。流速为1.0mL·min-1,并在242nm处监测流出物。苯磺酸氨氯地平和吲达帕胺的保留时间分别为5.9分钟和3.6分钟。该方法在线性,精度,精度和鲁棒性方面得到了验证。该方法已成功应用于组合片剂剂型中苯磺酸氨氯地平和吲达帕胺的估算。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号